Literature DB >> 8370480

Autoimmune diabetes results from genetic defects manifest by antigen presenting cells.

D V Serreze1.   

Abstract

In most cases, insulin-dependent diabetes results from autoimmune elimination of pancreatic beta cells by T lymphocytes that are generated as a result of complex polygenic interactions between particular MHC haplotypes and non-MHC linked susceptibility modifiers. Immature T cells with potential autoreactivity are normally destroyed in the thymus when they are highly activated after ligation of the T cell receptor (TCR) with "self" peptides bound to MHC molecules on antigen presenting cells (APC) such as macrophages. Here the hypothesis is put forth that non-MHC linked diabetes susceptibility genes contribute to subtle defects in the maturation of macrophages, and in synergy with a diabetogenic MHC haplotype generate APC that are unable to trigger autoreactive T cells to an activation state high enough to induce their destruction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370480     DOI: 10.1096/fasebj.7.11.8370480

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

1.  Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.

Authors:  K Goudy; S Song; C Wasserfall; Y C Zhang; M Kapturczak; A Muir; M Powers; M Scott-Jorgensen; M Campbell-Thompson; J M Crawford; T M Ellis; T R Flotte; M A Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Macrophages from nonobese diabetic mouse have a selective defect in IFN-γ but not IFN-α/β receptor pathway.

Authors:  Myung-Shik Lee; Hyung-Joon Kwon; Hun Sik Kim
Journal:  J Clin Immunol       Date:  2012-03-07       Impact factor: 8.317

Review 3.  Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.

Authors:  Ashley R Burg; Hubert M Tse
Journal:  Antioxid Redox Signal       Date:  2017-11-27       Impact factor: 8.401

4.  Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.

Authors:  H Rothe; N A Jenkins; N G Copeland; H Kolb
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

5.  Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet.

Authors:  J P Driver; O Foreman; C Mathieu; E van Etten; D V Serreze
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

6.  Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.

Authors:  Thomas Enzler; Silke Gillessen; Michael Dougan; James P Allison; Donna Neuberg; Darryl A Oble; Martin Mihm; Glenn Dranoff
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

Review 7.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

8.  Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice.

Authors:  A C Vasquez; M Feili-Hariri; R J Tan; P A Morel
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

9.  Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.

Authors:  C Gysemans; K Stoffels; A Giulietti; L Overbergh; M Waer; M Lannoo; U Feige; C Mathieu
Journal:  Diabetologia       Date:  2003-07-17       Impact factor: 10.122

10.  Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.

Authors:  Dan M Waid; Gisela M Vaitaitis; Nathan D Pennock; David H Wagner
Journal:  J Leukoc Biol       Date:  2008-05-09       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.